Moderna has been on a tear since mid-August. Citi now sees it plunging 60%
Analyst Geoff Meacham downgraded the biotech name to sell.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
